Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial)
A legfontosabb adatok
- Ki végzi
- Nanfang Hospital, Southern Medical University
- Hol
- Guangzhou (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 266 fő, tervezett
- Kezdés
- 2026. febr. 10.
- Várható befejezés
- 2030. jún. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Flow Diverter Group
- Stent Assisted Coiling Group
- A regiszteradat frissítve
- 2026. július 16.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with an unruptured, wide-neck bulge (aneurysm) where a brain artery splits in two. Participants get either a flow diverter or stent-assisted coiling.
- Életkor
- 18 to 75 years
- Nem
- All sexes can join.
- A betegség stádiuma
- Unruptured, saccular (sac-shaped), wide-neck aneurysm at a brain artery split, shown by DSA, CTA or MRA scans. Ruptured or narrow-neck aneurysms cannot join.
- Korábbi kezelés
- People who cannot take antiplatelet or anticoagulant (blood-thinning) medicines cannot join.
A részvétel fő kizáró okai
- Two or more aneurysms that all need treatment within 1 year
- Stroke (brain bleed or infarction) in the past 1 month, or other brain vessel disease such as moyamoya
- Poor daily function, modified Rankin Score ≥3, or life expectancy less than 12 months
- Serious heart, lung, liver, kidney or other disease that rules out anesthesia or the procedure
- Pregnant or breastfeeding women, or allergy to contrast media, cobalt-chromium or nickel-titanium
A regiszter feltételei, szó szerint
Mind a 18 feltétel megnézéseKevesebb
Ki vehet részt
- Age 18-75 years
- Diagnosis of unruptured intracranial, bifurcation, saccular, wide-neck aneurysm by DSA/CTA/MRA
- Patients who can understand the purpose of the trial, voluntarily participate and sign the informed consent form
Ki nem vehet részt
- Concomitant cerebrovascular diseases such as arteriovenous malformation, moyamoya disease
- Patients already scheduled for surgery/interventional procedure within 3 months
- Patients unable to receive antiplatelet or anticoagulant therapy
- Patients who have had or may have severe reactions to contrast media precluding pre-treatment medication
- Participation in other drug or medical device clinical trials before enrollment without reaching the primary endpoint timeframe
- Patients who have had a stroke (cerebral hemorrhage, cerebral infarction) within the past 1 month
- Extremely poor clinical condition, modified Rankin Score ≥3
- Patients unsuitable for anesthesia or endovascular surgery, such as major diseases of heart, lung, liver, spleen, kidney, brain tumors, severe active infections, disseminated intravascular coagulation, severe mental illness
- Patients with a definite history of allergy to cobalt-chromium, nickel-titanium alloy materials
- Patients with two or more multiple aneurysms that all require treatment within 1 year
- Ruptured aneurysms and narrow-neck aneurysms
- Patients deemed unsuitable for interventional treatment by the investigator (e.g., no suitable vascular access, excessively tortuous vessels, difficulty delivering stent)
- Pregnant or breastfeeding women
- Patient's life expectancy less than 12 months
- Investigator judges that the patient has poor compliance and cannot complete the study as required
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 75 év között vagy?
Helyszínek itt: Kína
- Nanfang Hospital, Southern Medical UniversityGuangzhou, KínaContact: Huibin Kang, MDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Brief Summary:
A teljes eredeti leírásKevesebb
The goal of this clinical trial is to compare whether the traditional approach (stent-assisted coiling) is associated with a lower complication rate than flow diverter (Pipeline™) treatment for unruptured intracranial wide-neck bifurcation aneurysms. It will also evaluate the long-term imaging outcomes and safety of both treatments. The main questions it aims to answer are:
* Does the traditional approach result in a lower rate of any stroke or all-cause death within one year after treatment compared to the flow diverter? * What medical problems do participants experience during and after each treatment? * What are the imaging cure and stability rates at 1, 2, and 5 years after treatment?
Researchers will compare the traditional approach (stent-assisted coiling) with the flow diverter (Pipeline™) to determine which treatment has better safety and efficacy outcomes.
Participants will:
* Be randomly assigned to receive either the flow diverter or traditional stent-assisted coiling * Undergo the assigned endovascular procedure * Return for follow-up visits at 30 days, 6 months, 1 year, 2 years, and 5 years after surgery for clinical assessments and imaging examinations (DSA, MRA, or CTA)
A vizsgálat 2 csoportja
- Stent Assisted Coiling GroupMár használt kezelés, összehasonlításként
Traditional Group (Stent Assisted Coiling): The patient is placed in a supine position. After satisfactory general anesthesia, the right groin area is routinely disinfected and draped. The right femoral artery sheath is replaced with an 8F sheath. Systemic heparinization is administered, followed by continuous pressurized infusion. A 6F long sheath plus a 5F multifunction catheter are advanced with a Terumo guidewire, and the long sheath is positioned in the left vertebral artery. A micro guidewire is used with a microcatheter to selectively catheterize the left posterior cerebral artery P2 segment, and then the microcatheter is advanced into the aneurysm. Through the microcatheter, one coil is semi deployed to form a framing coil, then one stent is deployed through the stent catheter to cover the aneurysm neck. After the first framing coil is detached, several additional coils are sequentially deployed to embolize the aneurysm. Follow up angiography shows no opacification of the a
- Flow Diverter GroupA vizsgált kezelés
Flow Diverter Group: The patient is placed in a supine position. The right groin area is routinely disinfected and draped. Local infiltration anesthesia is applied at the puncture site, and the right femoral artery is punctured using the Seldinger technique. An 8F sheath is inserted, systemic heparinization is administered, and continuous pressurized infusion is started. A 6F long sheath is advanced to the origin of the right internal carotid artery with the assistance of a Terumo guidewire and a multifunction catheter. A 5F intermediate catheter is advanced inside the long sheath to the petrous segment of the right internal carotid artery. 3D cerebral angiography is performed, and after a suitable working angle is obtained, a stent catheter is advanced to the right middle cerebral artery M3 segment with micro guidewire assistance. Manual injection shows no hemorrhage, confirming the true lumen. After calibration and measurement, one flow diverter stent is deployed to cover the ane
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Traditional Approach Versus Flow Diverter for Unruptured Intracranial Wide-neck Bifurcation Aneurysms: a Prospective International Multicenter Randomized Controlled Study (FD-BWA Study)
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT07707076: ki vehet részt
- A regiszteradat frissítve
- 2026. július 16.